• You are here
  • Home

Drug Discovery Hub Dortmund

Ersatzneubau Chemie und Physik

The Drug Discovery Hub Dortmund network is unique in Europe and combines all of the essential players in early-stage drug discovery and development in one collaborative project.

The TU Dortmund is coordinator and collaborates with the neighboring Leibniz Institute for Analytical Sciences (ISAS), the Leibniz Research Centre for Working Environment and Human Factors (IfADo) and the Max Planck Institute for Molecular Physiology (MPI), the BioMedizinZentrum (BMZ) and the local companies Lead Discovery Center (LDC), Taros and PROvendis.

The Drug Discovery Hub Dortmund (DDHD) is set up to serve as an incubator for drug discovery research projects throughout North Rhine-Westphalia (NRW).
It addresses professionally and sustainably, the core missions of drug discovery research, project scouting, financing, and industrial application. DDHD accomplishes this by concentrating the distributed competences of its partners in a sustainably synergistic infrastructure that functions as a development pipeline. In doing so, it makes a lasting contribution to NRW as an innovation location by translating excellent research into practice.

The Drug Discovery Hub Dortmund is funded in the scope of the NRW research infrastructures program ("Forschungsinfrastrukturen NRW Programm") of the state of North Rhine-Westphalia with funds from the European Fund for Regional Development (EFRE).

UA Ruhr-Forscher entwickeln gemeinsam Grundlagen für gezielte Krebstherapie

Preclinical Efficacy of Covalent-Allosteric AKT Inhibitor Borussertib in Combination with Trametinib in KRAS-mutant Pancreatic and Colorectal Cancer

Targeting the MKK7-JNK Pathway with Covalent Inhibitors.

Symposium 11th April 2019 “Laboratory animal-free future - How we can make it better today“